{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:55:27Z","timestamp":1784840127668,"version":"3.55.0"},"reference-count":30,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s307194","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T01:42:40Z","timestamp":1621302160000},"page":"2055-2061","source":"Crossref","is-referenced-by-count":14,"title":["Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Charles","family":"Blizzard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5437-5903","authenticated-orcid":true,"given":"Eugene B","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Q","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilatha","family":"Vantipalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Lynne","family":"Metzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3892\/etm.2017.5639","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/OPTH.S238756","volume":"14","author":"Brooks","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1631\/jzus.2006.B0675","volume":"7","author":"Yang","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"key":"ref4","first-page":"49","volume":"32","author":"Sacchetti","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Safety"},{"key":"ref6","first-page":"2131","volume":"7","author":"Rosin","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jtos.2019.11.006","volume":"18","author":"Zhang","year":"2020","journal-title":"Ocul Surf"},{"key":"ref8","first-page":"235","volume":"90","author":"Singh","year":"1992","journal-title":"J Indian Med Assoc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.4103\/0301-4738.73693","volume":"59","author":"Robin","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5935\/0004-2749.20170058","volume":"80","author":"Gomes","year":"2017","journal-title":"Arq Bras Oftalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/IJG.0b013e31820bd2e1","volume":"21","author":"Gupta","year":"2012","journal-title":"J Glaucoma"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S0161-6420(02)01967-X","volume":"110","author":"Solomon","year":"2003","journal-title":"Ophthalmology"},{"key":"ref14","unstructured":"Sawhney AS, Bassett M, Blizzard C. Drug delivery through hydrogel plugs. US Patent 8409606B2; 2013. Available from: https:\/\/patentimages.storage.googleapis.com\/8e\/df\/8d\/27cebf6bb8bbee\/US8409606.pdf. Accessed April 14, 2021."},{"key":"ref15","volume-title":"Emerging Concepts in Analysis and Applications of Hydrogels","year":"2016"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4155\/tde-2020-0010","volume":"11","author":"Tyson","year":"2020","journal-title":"Ther Deliv"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcrs.2018.09.023","volume":"45","author":"Tyson","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4172\/2155-9570.1000572","volume":"7","author":"Walters","year":"2016","journal-title":"J Clin Exp Ophthalmol"},{"key":"ref19","unstructured":"Ocular Therapeutix, Inc. Dextenza\u00ae (Dexamethasone Insert) for Intracanalicular Use. Prescribing Information. Bedford, MA: Ocular Therapeutix, Inc.; 2019."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/PPA.S126283","volume":"11","author":"Gira","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jop.2016.0154","volume":"33","author":"Torkildsen","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref22","unstructured":"ClinicalTrials.gov. OTX-15-002: a Phase 3 study evaluating the safety and efficacy of OTX-DP for the treatment of chronic allergic conjunctivitis. Identifier: NCT02988882. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02988882?term=ocular+therapeutix&draw=3&rank=17. Accessed April 14, 2021."},{"key":"ref23","unstructured":"World Medical Association. WMA declaration of Helsinki \u2013 ethical principles for medical research involving human subjects; 2018. Available from: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/. Accessed 16 March 2021."},{"key":"ref24","unstructured":"Ocular Therapeutix, Inc. Dextenza\u00ae (Dexamethasone Ophthalmic Insert) 0.4 Mg for Intracanalicular Use [Prescribing Information 2019]. Bedford, MA: Ocular Therapeutix, Inc.; 2019."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2147\/OPTH.S118409","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12886-017-0473-8","volume":"17","author":"Moore","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"ref27","unstructured":"Allergan USA, Inc. Ozurdex\u00ae (Dexamethasone Intravitreal Implant) for Intravitreal Injection [Prescribing Information 2018]. Madison, NJ: Allergan USA, Inc.; 2018."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0161-6420(02)01176-4","volume":"109","author":"Weijtens","year":"2002","journal-title":"Ophthalmol"},{"key":"ref29","unstructured":"Alcon Laboratories, Inc. Tobradex\u00ae ST (Tobramycin\/Dexamethasone Ophthalmic Suspension) 0.3%\/0.05% [Prescribing Information 2011]. Fort Worth, TX: Alcon Laboratories, Inc.; 2011."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s40265-020-01344-6","volume":"80","author":"Lee","year":"2020","journal-title":"Drugs"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69531","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69531","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T01:42:50Z","timestamp":1621302170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/plasma-pharmacokinetic-parameters-of-dexamethasone-following-administr-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2147\/opth.s307194","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}